Lege Artis Medicinae

[Development of anticoagulation in the past two decades]

SAS Géza

MAY 20, 2011

Lege Artis Medicinae - 2011;21(05)

[In the past two decades we have witnessed a gradually increasing significance of both prophylactic and therapeutic anticoagulation. The importance of thromboprophylaxis has become widely accepted in the course of surgical interventions and in various other fields of medicine, too. The introduction of low molecular weight heparins was a milestone in this respect. The need for long-term anticoagulation has become a common problem. The various recent aspects and topics of anticoagulation have been described in the current Hungarian medical literature, therefore, I focus on two general problems of medicine of our days from the aspects of our subject. The evaluation of information on the new, direct-acting inhibitors (anti-IIa and anti- Xa),and their high price present great difficulies, especially in the case of long-term anticoagulation therapy. Clinical data and experiences have been collected from patients who are greatly different from the majority of patients in the real world. The lack of antidote may also be a serious problem in case of these new drugs, as urgent neutralization might be necessary, for example in case of serious bleeding, accidents etc. Today, cost-effectiveness of medical interventions and drugs has become a major aspect, therefore, the high price of new anticoagulants might prevent their use in the clinical practice. Despite the optimistic expectations regarding new anticoagulants, at present we have to strive to treat our patients with the currently available, effective but affordable drugs, widening and improving their use.]

COMMENTS

0 comments

Further articles in this publication

Lege Artis Medicinae

[Acute hepatitis caused by herpes simplex virus 1]

PATYI Márta, SEJBEN István, VÁGÓ Tibor, CSERNI Gábor, KISS Antal Zsolt, KISS József Zoltán

[INTRODUCTION - Herpes simplex virus is a rare and severe disease, which is often lethal, especially in children and those who underwent transplantation. Rapid diagnostic help determines therapy and facilitates recovery of the patient. CASE REPORT - The authors present a case of a 46-year-old patient with no underlying disease, in whom the diagnosis of hepatitis caused by herpes simplex-1 virus was suggested after histological evaluation of a blind liver biopsy specimen. The diagnosis was later confirmed by immunomorphological examination. The patient’s hepatitis resolved following acyclovir therapy, but he developed nosocomial pneumonia, sepsis caused by Candida albicans and anuria. The patient recovered due the joint efforts of an infectologist, a pathologist, an intensive care specialist and a nephrologist. CONCLUSION - During examination of the patient, immune suppression was not indicated either by HIV-serology or bone marrow biopsy. thus the findings were presumably explained by a generalised infection in an immunocompetent host. In the case described, histological examination of the liver biopsy was a life-saving procedure, because it allowed timely and efficient treatment.]

Lege Artis Medicinae

[The place of sulphonylurea compounds in the blood glucose lowering therapy of type 2 diabetes]

WINKLER Gábor

[The mechanism of blood glucose lowering action of sulphonylureas, their advantages and potencial risks are overviewd in the article. The author delineates the present place of the sulphonylurea group in the antihyperglycemic therapy of type 2 diabetes, listing possibilities of monotherapeutic as well as combined applications. It is emphasized that traditional insulin-secretagogue compounds have their place in the therapy of type 2 diabetes even beside of the new, incretin-type secretagogues.]

Lege Artis Medicinae

[Successful treatment with fulvestrant - case report and some considerations]

RUBOVSZKY Gábor

Lege Artis Medicinae

[Comment]

WITTMANN István

Lege Artis Medicinae

[Man is not Made for Defeat – Hemingway’s Pathography]

KISS László

All articles in the issue

Related contents

Lege Artis Medicinae

[The choice of antibiotic therapy from the viewpoint of an economist]

KIS Zoltán

[OBJECTIVES - Antimicrobial resistance (AMR) in various bacterial infections is a growing problem in everyday clinical practice. The development of resistance is related to the clinical use of antibiotics, which substantially influences the efficiency of antimicrobial therapy. Inappropriately chosen therapy may increase the cost of treatment because of reduced efficacy and potential unwanted outcomes, adverse effects. Prolonged duration of treatment and increased use of diagnostic and therapeutic resources (including all medication expenses) contribute to the increased costs of treatment. The aim of our study was to demonstrate the differences in the total cost of therapy during hospitalization in certain patient groups, depending on the efficiency of the chosen antibiotic therapy. METHODS - We examined acute abdominal episodes, which represent one of the most typical surgical diseases. We analysed 59 hospital in-patient episodes that occurred in a six-month period, using aggregated hospital data. On the basis of the first choice of antibiotic we compared the average duration of antibiotic therapy and hospital stay, the incidence of medical complications and the cost of all these factors. RESULTS - The available results of our pilot study show that the length of hospital stay and the total cost of treatment may substantially increase even in the short term as a result of an inadequate choice of antibiotic, as the total cost of treatment is affected not only by the daily cost of antibiotic therapy, but also by its efficiency. In the long term, the risk of potentially developing resistance also necessitates an accurate choice of therapy, which requires institutional infection control and the prescription and implementation of protocols. These must be supported by cost-effectiveness analyses that include costs as well as results.]

Hypertension and nephrology

[Arterial hypertension and atrial fibrillation - the most important risk factors for stroke in clinical practice ]

LUDOVIT Gaspar, VESTENICKA Veronika, CAPRNDA Martin

[Vascular stroke is a very frequent cause of morbidity and mortality, and in patients who suffered stroke subsequent long-term neurological deficit of greater or lesser extent is an important factor. Numerous clinical and epidemiological studies confirmed that elevated systemic blood pressure is among the main risk factors of both ischemic and hemorrhagic vascular stroke, the effects of arterial hypertension being very complex including morphological and functional changes in vessels and vascular circulation. In our retrospective analysis of 218 patients hospitalized for stroke we found arterial hypertension in 91.2% of subjects and atrial fibrillation in 32.1% of subjects. 182 patients (83.5%) have been diagnosed with ischemic stroke and 36 patients (16.5%) with hemorrhagic stroke. In the group of patients with atrial fibrillation, only 33 patients (47.1%) were treated by anticoagulants, what points out an inadequate indication of anticoagulant treatment when considering the stroke risk calculation for atrial fibrillation (CHA2DS2- VASc Score) and bleeding risk (HAS-BLED Calculator for Atrial Fibrillation). It is also noteworthy that in the group of patients with anticoagulant therapy who have developed ischemic stroke in spite of this treatment, we found that in 48.5% the treatment was underdosed and therefore ineffective. Our work points to the need to improve the effective management of arterial hypertension and atrial fibrillation, the most common modifiable factors of vascular strokes.]

Lege Artis Medicinae

[COST-EFFECTIVENESS OF PIMECROLIMUS CREAM - A NEW TREATMENT FOR ATOPIC DERMATITIS IN HUNGARY]

KÓSA József, HUNYADI János, SZALAI Zsuzsanna, KÖRMENDY Miklós, KALÓ Zoltán

[OBJECTIVE - To assess the costs, consequences and cost-effectiveness of pimecrolimus cream 1% in the treatment of children with atopic dermatitis in Hungary. METHODS - A Markov-model for atopic dermatitis developed by the Erasmus University (Rotterdam, the Netherlands) was adopted to the Hungarian health care setting. The model is based on a double-blind, multicenter, randomized, parallelgroup study. Patients were randomised (2:1) to receive pimecrolimus treatment (i.e. emollients, pimecrolimus, medium potency topical corticosteroids) or standard of care (emollients, vehicle, medium potency topical corticosteroids). The study was conducted in children and adolescents (2 to 18 years of age). Hungarian cost vectors were calculated by linking severity of disease as defined by Investigator’s Global Assessment (IGA) to average resource use. Resource use was multiplied by drug costs and unit costs as published in official databases. RESULTS - Pimecrolimus treatment has an incremental cost of HUF 143 897 over standard care. This additional cost of care resulted in an incremental 0.05 QALY gain over the 6 months period. The incremental cost effectiveness ratio was 2 863 913 HUF/QALY for the pimecrolimus therapy. CONCLUSION - Pimecrolimus is more costeffective than many other health care interventions currently reimbursed by the Hungarian National Health Fund.]

LAM KID

[Efficiency of osteoporosis treatment in Hungary - An analysis of the Hungarian National Insurance Company’s data]

LAKATOS Péter, TÓTH Emese, SZEKERES László, POÓR Gyula, HÉJJ Gábor, TAKÁCS István

[The treatment of osteoporosis and its consequences place a significant burden on the health care of developed countries. Modern therapeutical approaches are able to efficiently decrease the risk of osteoporotic bone fractures. However, we do not know whether the interventions introduced in the past 15 years have significantly reduced the number of osteoporotic fractures in real life, and if they have, how cost-effective this effect was. To answer these questions, we have analysed data of the Hungarian National Insurance Company collected between 2004-2010. During these 7 years, the number of bone fractures among patients treated for osteoporosis continuously decreased. This was also observed in the incidence of hip fractures. Interestingly, the mortality of osteoporotic patients was significantly lower than that of the same age group in the average population. Besides the efficient treatment of osteoporosis, this finding is also due to the outstanding general care provided by the specialised osteoporosis centers of the country. As a consequence of the reduction in fractures, 3.4 billion HUF was saved per year by the insurance company, which is approximately equal to the 3.5 billion HUF spent on the reimbursement of medicines used for the treatment of osteoporosis, which means that the investments show a return. The calculation of the quality- adjusted life years, which is the internationally accepted method of the WHO for the study of cost-effectiveness, shows that the above results were achieved in a remarkably cost-efficient way. At the same time, it is noteworthy and calls for caution that the decrease in reimbursement by the insurance company in 2007 resulted in a 51% drop in the number of patients receiving treatment, which radically reduced the observed efficiency.]

Journal of Nursing Theory and Practice

[Comparison of the cost-effectiveness of vacuum assisted closure, as an innovative procedure, and traditional wound treatment, in the light of quality aspects]

LAKATOSNÉ PRIPKÓ Judit

[Recent decades have seen expansion in the literature and fi ndings related to the healing of wounds, and many new options for promoting wound healing have become available. The innovative wound treatment procedure known as vacuum assisted closure can be used for a wide range of indications, and can ensure the optimal conditions for the start of the wound healing processes. The study reveals the cost implications of negative pressure therapy through a study of the treatment of two patients, and also presents the components of the quality aspects identifi ed at Hatvan hospital, as defi ned in the Donabedián model, the PDCA cycle of the applied vacuum-assisted wound treatment, and the impact of the revealed components on the quality and costeffectiveness of the patient care. The author emphasises that the use of even the latest technologies can only effectively ensure the development of healthcare if combined with the commitment of managers and workers to assure quality, and if the fundamental principles of quality improvement are integrated into the structure and process of healthcare provision.]